Chau Thien Tay
Dr. Chau Thien (Jillian) Tay is a respected endocrinologist and clinical academic, known for her significant contributions to the field of women's health and polycystic ovary syndrome (PCOS) research. After completing her medical degree at the University of Tasmania, Dr. Tay pursued specialized training in Endocrinology through the RACP Basic and Advanced Physician Training program where she gained invaluable clinical experience. In 2021, Dr. Tay earned her Doctor of Philosophy (PhD) from Monash University, a milestone that was recognized with the distinguished Mollie Holman award for the best thesis of the year within the Faculty of Medicine, Nursing, and Health Sciences. She continued a combined clinical and research career postdoc where her research focused on the complexities of polycystic ovary syndrome and its implications for women's health, demonstrating her expertise and commitment to advancing medical knowledge.
Dr. Tay outstanding achievements in the research have been acknowledge by national and international peers. Notably, she was honoured with the Outstanding Abstract Awards at the esteemed Endocrine Society Annual Meeting in 2020, the AHRA Women's Health Research and Translation Network Early and Mid-Career Researcher Funded Award in 2021 and the prestigious Roger Bartop Research Establishment Fellowship from the Royal Australasian College of Physicians (RACP) in 2022, a testament to her standing as a prominent figure in the medical community. Beyond her research accomplishments, Dr. Tay actively engages in leadership roles that underscore her commitment to mentorship and academic advancement. She serves as the Chair of the international Androgen Excess and Polycystic Ovary Syndrome Society (AEPCOS) Early Career Special Interest Group, the chair of the national Centre of Research Excellence in Women's Health in Reproductive Life (CRE WHiRL) Early to Mid-Career Researcher Collective, and is a member of the CRE WHiRL's Training and Mentoring Committee, exemplifying her dedication to nurturing the next generation of medical professionals.
In recognition of her research and leadership skills, Dr Tay was invited to lead the Evidence Team for the 2023 International PCOS Guideline, where she instigated the international early-mid career researcher network and coordinated and supervised the 52 systematic reviews and meta-analyses. These meticulous efforts directly contributed to shaping the PCOS Guideline recommendations, further solidifying her standing as a respected figure in her field.
Abstracts this author is presenting: